Substance Use Disorder Clinical Trial
Official title:
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Comparative Effectiveness Trial of Extended Release Buprenorphine Versus Treatment as Usual for Hospitalized Patients With Opioid Use Disorder
This study is a multi-site open-label randomized comparative effectiveness trial of a 28-day formulation of extended-release buprenorphine (XR-BUP) versus treatment as usual (TAU) for hospitalized patients with a moderate or severe opioid use disorder (OUD) seen by an addiction consultation service (ACS) and agreeing to initiate a medication for OUD (MOUD). Participants will be randomly assigned to XR-BUP or TAU to be received within 72 hours of anticipated hospital discharge. Follow up will occur at approximately 34, 90, and 180 days following hospital discharge.
The study will randomize approximately 314 hospitalized men and women ages 18 years and older with opioid use disorder (OUD) moderate or severe and who have not been taking prescribed medication for OUD (MOUD) for 14 days or more prior to hospitalization. Eligibility will be determined over one or more assessments during the index hospitalization. Once eligibility has been determined, participants will be randomized 1:1 to either a single injection of extended-release buprenorphine or TAU, which will include methadone, sublingual buprenorphine, or naltrexone. Connection to OUD care and ongoing MOUD following hospitalization will be per community standard. Participants will be assessed for engagement in OUD treatment by the presence of a legitimately prescribed MOUD on day 34 following hospital discharge. Further outcomes will be assessed at 90 and 180 days following hospital discharge. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03042832 -
Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention
|
N/A | |
| Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
| Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
| Withdrawn |
NCT05448118 -
Virtual MOUD Treatment- Virtual POC Toxicology
|
N/A | |
| Withdrawn |
NCT05440721 -
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
|
N/A | |
| Completed |
NCT03694327 -
Innovative Digital Therapeutic for Smoking Cessation
|
N/A | |
| Recruiting |
NCT01979133 -
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
|
Phase 3 | |
| Completed |
NCT02308878 -
Mobile Health Cognitive Stimulation in Heroin Users
|
N/A | |
| Completed |
NCT01189552 -
Depression Treatment for Low Income Substance Users
|
N/A | |
| Completed |
NCT01280916 -
Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment
|
Phase 1 | |
| Completed |
NCT02964897 -
Improving Linkage to Health and Other Services for Veterans Leaving Incarceration
|
N/A | |
| Not yet recruiting |
NCT06315660 -
VR Based Therapy to Treat Anxiety in Dual Diagnosis
|
N/A | |
| Completed |
NCT02579317 -
Project IMPACT: In-the-Moment Protection From Automatic Capture by Trigger
|
N/A | |
| Completed |
NCT01003834 -
Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care
|
N/A | |
| Completed |
NCT03538860 -
Validation of an Automated Online Language Interpreting Tool - Phase Two.
|
N/A | |
| Completed |
NCT02656745 -
Clinical Trial of Smoking Cessation Mobile Phone Program
|
N/A | |
| Active, not recruiting |
NCT03331354 -
Assessing the Effect of Distance Learning Vocational Rehabilitation on Employment Outcomes of Veterans With Psychiatric Illness and Histories of Legal Convictions
|
N/A | |
| Completed |
NCT02110693 -
The Tobacco, Alcohol, Prescription Medication and Other Substances Tool
|
N/A | |
| Not yet recruiting |
NCT06432985 -
Smoking Cessation CM for Veterans With or at Risk for Cancer
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05415891 -
The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta
|
N/A |